Entia Biosciences, Inc.
ERGO
$0.0001
-$0.0001-50.00%
| 12/31/2016 | 09/30/2016 | 06/30/2016 | 03/31/2016 | 12/31/2015 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 215.77% | -95.17% | -90.22% | -- | -75.78% |
| Total Receivables | 12.68% | -89.27% | -79.17% | -32.14% | -97.09% |
| Inventory | 73.20% | -75.64% | -89.41% | -74.28% | -16.04% |
| Prepaid Expenses | 41.90% | 139.74% | 97.60% | 35.95% | 23.21% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 82.62% | -68.07% | -78.14% | -75.62% | -70.67% |
|
|
|||||
| Total Current Assets | 82.62% | -68.07% | -78.14% | -75.62% | -70.67% |
| Net Property, Plant & Equipment | -44.04% | -39.94% | -34.54% | -22.81% | -24.13% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -19.82% | -31.56% | -31.18% | -32.07% | -32.15% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | 16.28% |
| Total Assets | -2.12% | -39.94% | -47.28% | -44.91% | -48.48% |
|
|
|||||
| Total Accounts Payable | 9.64% | 97.91% | 114.17% | 64.45% | 56.74% |
| Total Accrued Expenses | 93.57% | 113.96% | 73.51% | 51.11% | 110.91% |
| Short-term Debt | 163.11% | 29.43% | 16.17% | -45.04% | -35.71% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 69.83% | 89.99% | 77.54% | 21.25% | 25.59% |
|
|
|||||
| Total Current Liabilities | 69.83% | 89.99% | 77.54% | 21.25% | 25.59% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 163.11% | 29.43% | 16.17% | -45.04% | -35.71% |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 94.04% | 123.16% | 112.91% | 35.73% | 25.59% |
|
|
|||||
| Common Stock & APIC | 1.44% | -1.04% | -0.06% | 11.45% | 14.38% |
| Retained Earnings | -10.67% | -9.91% | -10.84% | -17.75% | -20.89% |
| Treasury Stock & Other | 82.85% | 70.16% | 59.32% | 45.54% | 39.86% |
| Total Common Equity | -148.51% | -463.88% | -1,585.09% | -221.98% | -578.15% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
|
|
|||||
| Total Common Equity | -148.51% | -463.88% | -1,585.09% | -221.98% | -578.15% |
| Total Preferred Equity | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -148.56% | -464.19% | -1,589.06% | -222.12% | -579.14% |
|
|
|||||
